Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,454
datasets available to search
ShareScore release 0.9.0
Dataset results
1,454 results for “secretion”
Fig. 2 in Chemical profile of the cutaneous gland secretions from male pampas deer (Ozotoceros bezoarticus)
Fig. 2.—Typical gas chromatography–mass spectrometry traces of gland secretions from a yearling pampas deer. Samples were collected during the breeding season (March in the Southern Hemisphere). The traces show the absence of lateral differences between secretions from digital, tarsal, and preorbital glands: upper traces are left secretions and lower are right.
Fig. 1 in Chemical profile of the cutaneous gland secretions from male pampas deer (Ozotoceros bezoarticus)
Fig. 1.—Detailed gas chromatography–mass spectrometry traces of the 4 kinds of samples analyzed. Samples were collected during the breeding season (March in the Southern Hemisphere). Total ion chromatograms obtained from samples (preorbital, tarsal, and digital glands, and back hairs) from the same adult individual are shown. Magnified regions show the time range where a) short-chained compounds, b) esters, and c) fatty alcohols and sterols concentrate. Peak numbers show the most abundant or ubiquitous compounds and are as in Table 1 (XIII is a sulphurcontaining compound, LXI–LXII and CVI are fatty alcohols, C is an hydrocarbon, CII is squalene, CIX is a sterol, and CXX is cholesterol).
Fig. 4 in Chemical profile of the cutaneous gland secretions from male pampas deer (Ozotoceros bezoarticus)
Fig. 4.—Compound classes that exhibited significant differences related to sample origin. Different letters on columns indicate significant differences (P <0.05, MANOVA). Data were obtained from samples from the preorbital, tarsal, and digital glands, and back hairs of 6 adult and 5 yearling male pampas deer that were collected during the breeding season (March in the Southern Hemisphere).
Data from: Collective protection against the type VI secretion system in bacteria (The ISME Journal 2023)
<p>Raw experimental data as presented in Granato, Smith & Foster The ISME Journal 2023.</p> <p>Data used to prepare each figure can be found under separate tabs.<br> Tabs are labelled with their corresponding figure number in the manuscript.</p>
FIG. 3 in No Evidence for Across-Population Scent Discrimination of Cloacal Gland Secretions in Tuatara (Sphenodon punctatus)
FIG. 3. Probability that the tested Tuatara that had yet to approach the (A) 60-cm circle and (B) 30-cm circle across time. Probability of 1 denotes no Tuatara entered the circles, and probability of 0 denotes all experimental Tuatara have entered the circles. 1,400 min was appended to the end of experimental trial.
FIG. 2 in No Evidence for Across-Population Scent Discrimination of Cloacal Gland Secretions in Tuatara (Sphenodon punctatus)
FIG. 2. (A) Bird's-eye view of relative locations of all 12 Tuatara burrows and an expanded view of the test arena for each burrow. (B) Detail of mesh cage staked to the ground with odor sample in a sterile petri dish.
FIG. 1 in No Evidence for Across-Population Scent Discrimination of Cloacal Gland Secretions in Tuatara (Sphenodon punctatus)
FIG. 1. Medial view of the lateral wall of the nasal cavity of Sphenodon punctatus showing the location of the vomeronasal organ within the internal nares. Arrows denote direction of chemosensory odorants into the olfactory organ and vomeronasal organ. Diagram modified from Hoppe (1934). Anterior concha (AC), choanal fold (CF), choanal tube (CT), dorsal pocket of the choanal tube (DPC), external nares (EN), nasal cavity (NC), ventral conchal space (VCS), vomeronasal organ (VNO).
Combined immune checkpoint blockade increases myocardial secretion of H-FABP, NT-Pro-BNP, NLRP-3 inflammasome, Interleukin-1β and Interleukin-6: biochemical implications in cardio-immuno-oncology
<p>Background: Immune checkpoint inhibitors have transformed the treatment of several cancers by releasing restrained antitumor immune responses. Ipilimumab, an anti–cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) antibody, and nivolumab, an anti–programmed death-1 (PD-1) antibody, have individually improved survival in patients with melanoma, and their combination further enhances antitumor activity and survival. More recently, an anti-LAG3 human monoclonal antibody, Relatlimab, has been approved by FDA for combinatorial treatment with Nivolumab for metastatic melanoma and an anti-PD-L1 mAb,Atezolizumab, is undergoing clinical trials evaluation in combination with Ipilimumab for metastatic lung cancer.However,adverse events associated with these agents include dermatitis, endocrinopathies, colitis, hepatitis, and pneumonitis, which are all thought to arise from aberrant activation of autoreactive T cells. These toxic effects are more frequent and severe when immunomodulatory mAbs are used in combination. </p> <p>Methods: human cardiomyocytes co-cultured with hPBMC were exposed to monotherapy and combinatorial ICIs (PD-L1 and CTLA-4 or PD-1 and LAG-3 blocking agents, at 200 nM) for 48 h. After treatments, cardiac cell lysis and secretion of biomarkers of cardiotoxicity (H-FABP, NT-Pro-BNP), NLRP3-inflammasome and Interleukin 1 and 6 were determined through colorimetric and enzymatic assays. <strong>Results:</strong>Both Combinations of immune checkpoint inhibitors exertmore potent cardiotoxic side effects compared to monotherapies against human cardiac cells co-cultured with human lymphocytes. LDH release from cardiac cells was 43% higher in PDL-1/CTLA-4 blocking agents, and 35.7% higher in PD-1/LAG-3 blocking agents compared to monotherapies. Biomarkers of cardiotoxicity, such as H-FABP and NT-Pro-BNP were also strongly increased in combination therapy than monotherapies. NLRP3 inflammasome, IL-1β and IL-6 levels were also increased by PDL-1/CTLA-4 and PD-1/LAG-3 combined blocking agents compared to untreated cells and monotherapies. </p> <p><strong>Conclusions:</strong>Data of the present study, although in vitro, indicate that combinatorial immune checkpoint blockade on co-cultures of hPBMCs and cardiac cells, including for the first time the anti LAG-3 monoclonal antibody, induce a pro- inflammatory phenotype, thus indicating that these therapies should be closely monitored by the multidisciplinary team consisting of oncologists, cardiologists and immunologists.</p>
Fig. 8. Compound 4 inhibited IL-1 in Guaianolides from Artemisia codonocephala suppress interleukine-1β secretion in macrophages
Fig. 8. Compound 4 inhibited IL-1β production in THP-1 macrophages. (A) Immunofluorescence staining of IL-1β was performed. Scale bar = 10 μm. (B) The protein level of IL-1β in the culture medium from THP-1 cells was determined by ELISA. (C) Cleaved IL- 1β, NLRP3 and Caspase 1 in the supernatant or lysates of THP-1 cells were detected by western blotting. GAPDH was used as an internal loading control. (D) Expression of autophagy related proteins were detected by Western blotting. GAPDH was used as an internal loading control. (E) Expression of autophagy related proteins in THP-1 cells treated with or without 10 μM compound 4 and 5 mM 3-MA. GAPDH was used as an internal loading control. (F) mRFP- GFP-LC3 puncta were measured using a confocal microscope. Scale bar = 5 μm. (G) The levels of IL-1β in the culture medium from THP-1 cells treated with or without 10 μM compound 4 and 5 mM 3-MA. Data are expressed as means ± SD (n = 6). ###P <0.001, LPS + ATP vs. control, **P <0.01 and ***P <0.001, 4 vs. LPS + ATP.
Fig. 7 in Guaianolides from Artemisia codonocephala suppress interleukine-1β secretion in macrophages
Fig. 7. The HPLC-HRESIMS result (1–11min) of the acetone extract and the identification of the undescribed compounds of Artemisia codonocephala.
Fig. 3 in Stimulation of insulin secretion by 5-methylcoumarins and its sulfur analogues isolated from Clutia lanceolata Forssk
Fig. 3. Effects of test compounds (from Clutia lanceoleta) on the glucose-triggered secretion of insulin from murine islets. Islets were incubated for 1 h at 37 °C in KRB buffer containing glucose (16.7 mM) in the absence (Control) or presence of test compounds and the secreted insulin was measured. Values are mean ± SD from three independent experiments. *P <0.05, **P <0.01, ***P <0.001 compared with the control value.
Fig. 2. X-Ray crystal structures determined for 1,8,9,11,12,14–17,19,20 in Stimulation of insulin secretion by 5-methylcoumarins and its sulfur analogues isolated from Clutia lanceolata Forssk
Fig. 2. X-Ray crystal structures determined for 1,8,9,11,12,14–17,19,20. Atoms are shown as thermal ellipsoids drawn at the 50% probability level.
Fig. 1 in Stimulation of insulin secretion by 5-methylcoumarins and its sulfur analogues isolated from Clutia lanceolata Forssk
Fig. 1. Structures of 5-methylcoumarins isolated from Clutia lanceolata. Compounds 1–13 are undescribed, whereas 14–21 are known but are isolated from this plant for the first time. Also shown is the chemical numbering scheme for the ring and its substituents.
Le Secret
"Le Secret" by René Béclu, 1913 Currently exposed in Parc de la Tête d'Or, Lyon, France Made from 897 pictures taken with a Nikon D7000. Source: Objaverse 1.0 / Sketchfab
Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects
ClinicalTrials.gov study NCT00651105. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
ClinicalTrials.gov study NCT06061926. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CRISAL Study:Cancer Risk In Secreting Adrenal Lesions
ClinicalTrials.gov study NCT06520111. IPD Sharing: YES. Countries: 1. Publications: 9.
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
ClinicalTrials.gov study NCT02231658. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT01374594. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effect of, OAT3, on the Renal Secretion of Cefotaxime
ClinicalTrials.gov study NCT00187655. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.